ABL

Abbott Laboratories · FWB:ABL

93.96 EUR−0.5600 −0.59%

Abbott Laboratories (FWB:ABL) last traded at 93.96 EUR, down 0.59% on the day. Over the past year the stock is down 12.42%. Its 52-week range is 69.76 to 112.56. It is in the Health Technology sector (Medical Specialties).

Key statistics

Open93.96

Day range93.96 – 93.96

52-week range69.76 – 112.56

Volume50

Average volume (10 days)111

Market cap (USD)183.77 B

P/E39.30

EPS (TTM) (USD)2.71

Dividend yield2.37%

Beta (1 year)0.3618

Revenue (TTM) (USD)48.23 B

Employees115.00 K

Performance

+3.75%1 week

+9.66%1 month

+1.25%3 months

+26.80%6 months

−11.79%Year to date

−12.42%1 year

Technical reading

Bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Notable analyst calls this week: Broadcom, Moderna and Abbott among top picksSeeking Alpha · 31 Oct 2026
HHS proposes changes to infant formula standardsSeeking Alpha · 29 Oct 2026
Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve DiseaseReuters · 29 Oct 2026
Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve ReplacementReuters · 28 Oct 2026
Abbott downgraded at Argus on guidance cutSeeking Alpha · 27 Oct 2026
Abbott Labs Cut to Hold From Buy by Argus ResearchDow Jones Newswires · 27 Oct 2026
Weekly Recap: Tighter EPS outlook and Exact Sciences in Cancer DiagnosticsTradingView · 26 Oct 2026
Abbott Labs Is Maintained at Overweight by Wells FargoDow Jones Newswires · 23 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.